Skip to content

Study on Electroacupuncture in Treating Patients with Ischemic Stroke in the Rehabilitation Stage:a Pragmatic Randomized Controlled Trial

Study on Electroacupuncture in Treating Patients with Ischemic Stroke in the Rehabilitation Stage:a Pragmatic Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083199
Enrollment
Unknown
Registered
2024-04-18
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

test group:Acupuncture treatment with basic drug treatment and rehabilitation program. Acupoints include Baihui (GV-20), Shuigou (GV-26), Zhongchong (PC-9), Huantiao (GB-30), Fengshi (GB-31), Yangling
control group:Basic drug treatment and rehabilitation program, and rehabilitation treatment included or did not include conventional acupuncture treatment according to patients' wishes. Acupoint presc

Sponsors

The Affiliated TCM Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Patients with ischemic stroke in the rehabilitation stage (within 2 weeks to 6 months) ; ? First stroke or recurrent strokes=2 times; ? Aged between 40-75; ? Patients with stable vital signs, without significant cognitive impairment or hearing loss, who are capable of cooperating with acupuncture treatment and basic rehabilitation exercises.

Exclusion criteria

Exclusion criteria: ? Patients who participated in any other trials or received other alternative therapy that could affect the outcome of this trial; ? Patients diagnosed with transient cerebral ischemia or reversible ischemic neurological deficit (RIND); ? Patients with neurological deficits that are caused by diseases such as brain tumors, traumatic brain injury, cerebral hemorrhage, cerebral parasites,heart disease, or metabolic disorders; ? Patients with severe cardiopulmonary, hepatic, splenic, renal, or psychiatric conditions; ? Patients with complications such as severe aphasia, sleep apnea, deafness, severe cognitive impairment.

Design outcomes

Primary

MeasureTime frame
NIH Stroke Scale(NIHSS);

Secondary

MeasureTime frame
the modifid Barthel index(MBI);Fugl-Meyer Assessment(FMA);

Countries

China

Contacts

Public ContactChuyun Chen

The Affiliated TCM Hospital of Guangzhou Medical University

chencyzwl@126.com+86 139 2402 6576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026